GLP-1 drugs: what Utah Medicaid paid

Utah Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Utah Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Utah Medicaid’s payment record shows

In 2026Q1, the product Utah Medicaid paid for most often was Ozempic®, at 3,901 prescriptions¹⁹ of the 5,737 to 6,034^{1,7,13,19,25,37} across all 8 products, or 68 percent of the published count.

Utah Medicaid itself reimbursed at least $5,760,503 for these products in the quarter, about $1,010 per prescription. Pharmacies were paid $5,832,635 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,283.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Utah Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Utah Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Utah Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Utah Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both101 managed care, 130 direct	at least 231¹	4%	$239,048	$242,990	$1,035
tirzepatideMounjaro®	Both1,039 managed care, 226 direct	at least 1,265⁷	22%	$1,313,377	$1,354,456	$1,038
semaglutideWegovy®	Both64 managed care, 68 direct	at least 132¹³	2%	$169,372	$174,231	$1,283
semaglutideOzempic®	Both3,559 managed care, 342 direct	at least 3,901¹⁹	68%	$3,892,554	$3,914,806	$998
semaglutideRybelsus®	Both	at least 104²⁵	2%	$105,811	$105,811	$1,017
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both49 managed care, 22 direct	at least 71³⁷	1%	$40,341	$40,341	$568
liraglutideliraglutide (generic)	Both	Withheld	n/a	Not published	Not published	Not published

Utah Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 19.3 to 20.3 prescriptions per thousand people enrolled in Utah Medicaid, on an average of 296,751 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 18 of the 168 product-quarters it holds a row for here, which is 11 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Utah Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Utah Medicaid paid for each product, quarter by quarter

Prescriptions Utah Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²Withheld8 of 8 product codes withheld	at least 78 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$80,079 paid	at least 231 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$239,048 paid
tirzepatideMounjaro®range 801 to 2,625	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 16 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$15,309 paid	at least 88 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$90,322 paid	at least 221 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$228,840 paid	at least 219 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$222,617 paid	at least 235 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$235,573 paid	at least 331 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$347,098 paid	801 paid prescriptions in the quarter (2024Q2)⁹Count$838,721 paid	at least 1,237 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$1,286,005 paid	1,240 paid prescriptions in the quarter (2024Q4)⁹Count$1,276,639 paid	1,453 paid prescriptions in the quarter (2025Q1)⁸Count$1,510,914 paid	1,940 paid prescriptions in the quarter (2025Q2)⁸Count$2,047,264 paid	at least 2,359 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$2,493,888 paid	2,625 paid prescriptions in the quarter (2025Q4)⁸Count$2,779,077 paid	at least 1,265 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$1,313,377 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable¹⁵Withheld7 of 7 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable¹⁴Withheld7 of 7 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$11,807 paid	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable¹⁴Withheld9 of 9 product codes withheld	at least 38 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$50,060 paid	at least 132 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$169,372 paid
semaglutideOzempic®range 380 to 2,463	383 paid prescriptions in the quarter (2021Q1)²⁴Count$366,128 paid	380 paid prescriptions in the quarter (2021Q2)²⁴Count$398,469 paid	at least 413 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$503,874 paid	at least 536 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$553,263 paid	at least 563 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$667,592 paid	at least 664 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$820,155 paid	at least 785 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$738,548 paid	at least 864 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$818,043 paid	at least 1,049 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$999,048 paid	at least 1,270 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$1,198,343 paid	1,315 paid prescriptions in the quarter (2023Q3)²²Count$1,277,972 paid	1,312 paid prescriptions in the quarter (2023Q4)²²Count$1,320,071 paid	1,494 paid prescriptions in the quarter (2024Q1)²¹Count$1,483,420 paid	2,338 paid prescriptions in the quarter (2024Q2)²¹Count$2,347,408 paid	at least 2,525 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$2,477,352 paid	2,365 paid prescriptions in the quarter (2024Q4)²¹Count$2,329,004 paid	2,442 paid prescriptions in the quarter (2025Q1)²⁰Count$2,487,571 paid	2,463 paid prescriptions in the quarter (2025Q2)²⁰Count$2,554,343 paid	2,276 paid prescriptions in the quarter (2025Q3)²⁰Count$2,355,706 paid	2,436 paid prescriptions in the quarter (2025Q4)²⁰Count$2,465,344 paid	at least 3,901 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$3,892,554 paid
semaglutideRybelsus®range 60 to 222	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld4 of 4 product codes withheld	at least 14 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$21,361 paid	60 paid prescriptions in the quarter (2021Q3)³⁰Count$79,712 paid	at least 51 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$89,834 paid	at least 72 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$97,721 paid	at least 93 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$140,949 paid	at least 140 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$143,921 paid	at least 158 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$147,883 paid	at least 194 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$186,234 paid	at least 201 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$192,287 paid	at least 152 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$160,656 paid	at least 152 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$144,280 paid	at least 161 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$168,621 paid	222 paid prescriptions in the quarter (2024Q2)²⁷Count$243,099 paid	217 paid prescriptions in the quarter (2024Q3)²⁷Count$217,868 paid	at least 165 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$165,643 paid	at least 167 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$173,944 paid	at least 183 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$191,792 paid	at least 177 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$183,648 paid	at least 173 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$179,603 paid	at least 104 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$105,811 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 129 to 512	512 paid prescriptions in the quarter (2021Q1)⁴²Count$550,770 paid	504 paid prescriptions in the quarter (2021Q2)⁴²Count$489,744 paid	457 paid prescriptions in the quarter (2021Q3)⁴²Count$481,857 paid	438 paid prescriptions in the quarter (2021Q4)⁴²Count$420,348 paid	414 paid prescriptions in the quarter (2022Q1)⁴¹Count$430,410 paid	374 paid prescriptions in the quarter (2022Q2)⁴¹Count$429,482 paid	358 paid prescriptions in the quarter (2022Q3)⁴¹Count$328,007 paid	325 paid prescriptions in the quarter (2022Q4)⁴¹Count$300,669 paid	265 paid prescriptions in the quarter (2023Q1)⁴⁰Count$239,585 paid	299 paid prescriptions in the quarter (2023Q2)⁴⁰Count$272,422 paid	184 paid prescriptions in the quarter (2023Q3)⁴⁰Count$164,079 paid	168 paid prescriptions in the quarter (2023Q4)⁴⁰Count$144,647 paid	159 paid prescriptions in the quarter (2024Q1)³⁹Count$113,089 paid	168 paid prescriptions in the quarter (2024Q2)³⁹Count$121,398 paid	129 paid prescriptions in the quarter (2024Q3)³⁹Count$84,146 paid	at least 103 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$75,642 paid	at least 99 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$75,240 paid	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	at least 71 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$40,341 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 58 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$36,093 paid	at least 67 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$34,649 paid	103 paid prescriptions in the quarter (2025Q1)⁴⁴Count$57,340 paid	at least 101 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$51,686 paid	at least 85 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$37,497 paid	at least 87 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$28,668 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld9 of 9 product codes withheld

What this page cannot tell you

Whether Utah Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Utah in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, UT
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "78"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, UT
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "19"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, UT
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like ZEPBOUND%, state UT, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, UT
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like ZEPBOUND%, state UT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, UT
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like ZEPBOUND%, state UT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, UT
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like ZEPBOUND%, state UT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, UT
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "236"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, UT
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "520"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, UT
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "219"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, UT
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "60"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, UT
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, UT
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like MOUNJARO%, state UT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, UT
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 1.5", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, UT
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, UT
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, UT
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like WEGOVY%, state UT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, UT
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like WEGOVY%, state UT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, UT
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like WEGOVY%, state UT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, UT
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1438"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, UT
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "906"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, UT
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "726"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, UT
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "585"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, UT
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "390"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, UT
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "249"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, UT
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "52"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, UT
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, UT
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "74"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, UT
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "81"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, UT
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "64"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, UT
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, UT
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, UT
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, UT
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like SAXENDA%, state UT, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, UT
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like SAXENDA%, state UT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, UT
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, UT
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like SAXENDA%, state UT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, UT
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "27"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, UT
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, UT
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "71"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, UT
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "115"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, UT
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "191"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, UT
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "255"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, UT
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state UT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "UT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, UT
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state UT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "38"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, UT
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state UT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "35"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, UT
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state UT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like LIRAGLUTID%, state UT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, UT
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state UT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like LIRAGLUTID%, state UT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, UT
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state UT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "UT", "product_name": "product_name like LIRAGLUTID%, state UT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 34 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 14 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Utah Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.